Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients. Frolke SC, Amirkhan KG, van der Bom-Baylon N, van Gils M, et al. PLoS One 2026;21:e0336320.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Frolke SC, Amirkhan KG, van der Bom-Baylon N, van Gils M, et al. Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients. PLoS One 2026;21:e0336320.
PMID: 41774724